Bahrain vs Barbados: Access to anti-retroviral drugs, male
Bahrain
53.0%
in 2024
Barbados
57.0%
in 2024
Bahrain rank
112th
Barbados rank
109th
Access to anti-retroviral drugs, male over time
- Bahrain
- Barbados
How they compare
Barbados currently reports 57.0% against 53.0% in Bahrain, a difference of 4.0%.
That makes Barbados's figure about 1.1 times Bahrain's.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was Bahrain ahead.
Bahrain ranks 112th and Barbados ranks 109th of 141 countries.
Barbados has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bahrain | Barbados | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 9.9% | 17.7% | 7.8% | Barbados |
| 2010s | 30.1% | 44.9% | 14.8% | Barbados |
| 2020s | 52.2% | 54.4% | 2.2% | Barbados |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Bahrain or Barbados?
- Barbados, at 57.0% against 53.0% in Bahrain as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Bahrain and Barbados?
- 4.0%, with Barbados ahead.
- How many years of comparable data are there for Bahrain and Barbados?
- 25 years are reported by both, from 2000 to 2024.
- How do Bahrain and Barbados rank globally for access to anti-retroviral drugs, male?
- Bahrain ranks 112th and Barbados ranks 109th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.